Assignee
TARGOVAX OY
FI·3 granted patents·2 pending applications·28 citations·filing 2012–2021
Top patents by PatentIndex Score
5 records- 0189US9410129B2Recombinant serotype 5 (Ad5) adenoviral vectorsTARGOVAX OY·Filed 2012·Granted Aug 9, 2016·28 cites·29 claims
- 0255US11690913B2Combining adenovirus and checkpoint inhibitors for treating cancerTARGOVAX OY·Filed 2021·Granted Jul 4, 2023·0 cites·18 claims
- 0351US10940203B2Combining adenovirus and checkpoint inhibitors for treating cancerTARGOVAX OY·Filed 2017·Granted Mar 9, 2021·0 cites·16 claims
- 0449US2016208287A1Adenoviral vectors and methods and uses related theretoTARGOVAX OY·Filed 2016·Application pending·0 cites
- 0531US2019000898A1Combining adenovirus and chemotherapeutic agents for treating cancerTARGOVAX OY·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TARGOVAX OY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →